Voyager Therapeutics Inc. (VYGR) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Voyager Therapeutics Inc. is exposed to a broad array of risks that could negatively impact its business, financial condition, operating results, and long-term prospects, as detailed in its Form 10-K for the year ended December 31, 2025. An investor must also consider that additional, currently unknown or less significant risks may emerge over time, and that all forward-looking statements in its Form 10-Q are explicitly qualified by these risk factors.
Overall, Wall Street has a Strong Buy consensus rating on VYGR stock based on 9 Buys.
To learn more about Voyager Therapeutics Inc.’s risk factors, click here.